Previous 10 | Next 10 |
home / stock / bayry / bayry news
Bayer reported solid results for fiscal 2020 with revenue and core EPS being more or less stable compared to fiscal 2019. A few weeks ago, Bayer also settled the glyphosate litigations. Over the next few years, Bayer will return on the path of growth and several megatrends are hug...
Stocks performed strongly in February with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans while awaiting a market correction or possibly a real crash once market euphoria has come down. My dividend income amounted to $350, up 19% sequent...
Bayer ([[BAYRY]] +2.8%) says it now expects a U.S. court hearing on a proposed $2B settlement for possible future lawsuits over its Roundup weedkiller to occur on May 12, rather than March 31 as previously was expected.The settlement proposal would add $750M to the total bill of an outline se...
Evofem recently launched the first new non-hormonal birth control option in decades. Clinical efficacy falls short of the copper IUD, PARAGARD, but that device I believe may come with significant side effects. A trend in birth control centered on the woman's quality of life (safet...
TransCode Therapeutics has filed to raise $29 million in an IPO. The firm is developing treatments for metastatic cancer and other conditions. RNAZ has produced impressive results in preclinical mice studies. For further details see: TransCode Therapeutics Starts $29 Mil...
Outcry Grows Over Proposed Bayer AG Settlement of Monsanto Roundup Cancer Lawsuits Cancer victims criticize settlement proposal that would allow continued sales of cancer-causing herbicide, protect Bayer AG from future cancer claims PR Newswire SAN FRANCISCO , ...
Bayer AG (BAYZF) Q4 2020 Earnings Conference Call February 25, 2021, 04:00 ET Company Participants Oliver Maier - Head, IR Werner Baumann - Chairman, CEO, Labor Director & Chief Sustainability Officer Wolfgang Nickl - CFO Heiko Schipper - Head, Consumer Health Division Liam Condon - Presi...
Bayer (BAYRY) -4.2% in Frankfurt after reporting a 78% Y/Y decline in Q4 net profit to €308M ($374.9M) from €1.41B a year earlier.Q4 sales fell 7% Y/Y to ~€10B from €10.75B but in line with analyst consensus.Q4 EBITDA fell slightly to €2.39B from €2.4...
There is growing demand for AI use in drug development. Drug development deals go from $5 million to over $1 billion. Predictive Oncology has a unique platform using real patient samples in its AI process. Predictive Oncology could be undervalued if it can ink large or multipl...
This article is the fourth in a series designed to help investors decide for themselves if Jeremy Grantham's "epic bubble" call is correct. In this analysis, 129 of the 180 largest holdings of the Vanguard Total International ETF are put under the valuation microscope. These 129 I...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...